Traduction de «Absorption from the gastrointestinal tract » (Anglais → Français) :

digestive absorption [ absorption from the gastrointestinal tract ]

A very rare tumor of the intestine, originating from the epithelium of the anal canal (including the mucosal surface, anal glands, and lining of fistulous tracts), macroscopically appearing as a nodular, often ulcerated, invasive mass located in the

skin absorption [ cutaneous absorption | absorption from the skin | absorption through the skin ]

A rare epithelial tumor of the rectum, arising from squamous cells in the rectal epithelium, without the presence of squamous-lined fistulous tracts in the rectum or a proximal extension of squamous cell carcinoma of anal or gynecological origin. The

A rare non-syndromic urogenital tract malformation with the familial occurrence of retrograde flow of urine from the bladder into the ureter and sometimes the kidneys. Patients may be asymptomatic or may present with recurrent, sometimes febrile, uri

Definition: A disorder characterized by involuntary voiding of urine, by day and by night, which is abnormal in relation to the individual's mental age, and which is not a consequence of a lack of bladder control due to any neurological disorder, to epileptic attacks, or to any structural abnormality of the urinary tract. The enuresis may have been present from birth or it may have arisen following a period of acquired bladder control. The enuresis may or may not be associated with a more widespread emotional or behavioural disorder. | Enuresis (primary)(secondary) of nonorga ...[+++]nic origin Functional enuresis Psychogenic enuresis Urinary incontinence of nonorganic origin

Such experiments should include: One, the full characterization of hormones in bio-active substances in milk from rBGH treated cows, including compounds such as prostaglandins, progesterone, prolactin, thyroid hormones, gonadotropin-releasing hormone, thyrotropin-releasing hormone, growth hormone releasing factor, basoactive intestinal peptide, epidermal growth factor, estrogens, plasmin, interlukins, tumour necrosis factor, insulin, IGF-1, IGF-2 and growth hormone; two, the feeding of milk from rBGH cows to neonatal primates to determine the effects on gastrointestinal tract ...[+++] development, absorption and function; and three, the effect of consumption of milk from rBGH treated cows on immune recognition and subsequent immune functions in the gut.

There is a small amount of experimental information now this is in mice or experimental species to show that the potential absorption of IGF-1 from the gastrointestinal tract is actually reduced in a diabetic animal model.

In summary, the main toxicological concerns that have been raised with respect to the use of rBST are: (a) would rBST residues be absorbed intact from the gastrointestinal tract in sufficient quantities to produce a toxic and/or immunologic response; and (b) would IGF1 residues in milk or milk products survive the gastrointestinal tract environment to produce localized effects, or be absorbed intact and remain bioactive in sufficient quantities to produce systemic effects ...[+++]?

Gene transfer from GM goods to cells of the body or to bacteria in the gastrointestinal tract would cause concern if the transferred genetic material adversely affects human health.